NYSE: LLY - Eli Lilly and Company

Yield per half year: -12.12%
Sector: Healthcare

Company Analysis Eli Lilly and Company

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (36.83%) is higher than the sector average (-13.41%).
  • Current debt level 39.41% is below 100% and has decreased over 5 years from 40.21%.
  • The company's current efficiency (ROE=48.65%) is higher than the sector average (ROE=-80.87%)

Disadvantages

  • Price (579.6 $) is higher than fair price (69.12 $)
  • Dividends (0.6047%) are below the sector average (1.28%).

Similar companies

Humana

UnitedHealth Group

Johnson & Johnson

Bristol-Myers

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Eli Lilly and Company Healthcare Index
7 days 5% -12% 0.6%
90 days -12.5% -19.6% 2.1%
1 year 36.8% -13.4% 25.1%

LLY vs Sector: Eli Lilly and Company has outperformed the "Healthcare" sector by 50.24% over the past year.

LLY vs Market: Eli Lilly and Company has outperformed the market by 11.77% over the past year.

Stable price: LLY is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: LLY with weekly volatility of 0.7082% over the past year.

3. Summary of the report

3.1. General

P/E: 98.32
P/S: 15.1

3.2. Revenue

EPS 5.8
ROE 48.65%
ROA 8.19%
ROIC 26.2%
Ebitda margin 36.5%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (579.6 $) is higher than the fair price (69.12 $).

Price is higher than fair: The current price (579.6 $) is 88.1% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (98.32) is higher than that of the sector as a whole (57.85).

P/E vs Market: The company's P/E (98.32) is higher than that of the market as a whole (47.37).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (47.43) is higher than that of the sector as a whole (9.39).

P/BV vs Market: The company's P/BV (47.43) is higher than that of the market as a whole (22.69).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (15.1) is higher than that of the sector as a whole (4.05).

P/S vs Market: The company's P/S indicator (15.1) is lower than that of the market as a whole (15.16).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (43.16) is higher than that of the sector as a whole (17.49).

EV/Ebitda vs Market: The company's EV/Ebitda (43.16) is higher than that of the market as a whole (17.77).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -3.07% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-3.07%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-69.16%).

5.4. ROE

ROE vs Sector: The company's ROE (48.65%) is higher than that of the sector as a whole (-80.87%).

ROE vs Market: The company's ROE (48.65%) is higher than that of the market as a whole (17.14%).

5.5. ROA

ROA vs Sector: The company's ROA (8.19%) is higher than that of the sector as a whole (6.7%).

ROA vs Market: The company's ROA (8.19%) is higher than that of the market as a whole (6.51%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (26.2%) is higher than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (26.2%) is higher than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (39.41%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 40.21% to 39.41%.

Excess of debt: The debt is not covered by net income, percentage 481.36%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.6047% is below the average for the sector '1.28%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.6047% has been steadily paid over the past 7 years, DSI=1.

Dividend growth: Company's dividend yield 0.6047% has been growing over the last 5 years. Growth over 10 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (77.65%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
03.09.2024 LILLY ENDOWMENT INC
10% Owner
Sale 966.69 23 281 800 24 084
27.08.2024 LILLY ENDOWMENT INC
10% Owner
Sale 968.46 23 777 600 24 552
10.07.2024 LILLY ENDOWMENT INC
10% Owner
Sale 939.82 197 362 000 210 000
08.07.2024 LILLY ENDOWMENT INC
10% Owner
Sale 918.64 85 978 300 93 593
05.07.2024 LILLY ENDOWMENT INC
10% Owner
Sale 915.18 47 927 100 52 369

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Eli Lilly and Company

9.3. Comments